Proscia, a company that uses artificial intelligence to treat and research cancer, has raised $37 million in series C funding.
Read the full post on Becker's Hospital Review - Healthcare News
AI pathology firm Proscia nets $37M investment
Read the full post on Becker's Hospital Review - Healthcare News